About Nordic Vaccine
Nordic Vaccine is a Healthcare company based in Copenhagen (Denmark) founded in 2001, and was acquired by Isconova in May 2011. Adjuvants and vaccine delivery systems were developed for needle-free administration. Its focus areas include Diversified Pharmaceuticals, Life Sciences, Life Sciences Platforms and Tools and Research Services. Its legal entity is NORDIC VACCINE A/S.
Company details
Founded in 2001 in Copenhagen, Denmark, Nordic Vaccine operated in the biotechnology sector with a focus on research and development of adjuvants and drug delivery systems for vaccines. The companys portfolio featured the Posintro technology, a preclinical platform enabling needle-free vaccine delivery through dermal patches. Operations emphasized preclinical advancements until acquisition by Isconova in May 2011 for 663k.
- Headquarters Copenhagen, Denmark
- Stage Acquired
- SectorsHealthcare
- Website nordic-vaccine.dk
- Social LinkedIn
- Acquired by Isconova (May 2011)
- Legal Name Nordic Vaccine A/S
Funding Insights of Nordic Vaccine
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Nordic Vaccine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2011 | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Nordic Vaccine
Nordic Vaccine has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Isconova and Sunstone.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by Sunstone in early-stage European companies. | sunstone.eu | Copenhagen, Denmark | ||
Vaccine adjuvants are developed for infectious diseases and veterinary applications. | 1999 | isconova.com | Uppsala, Sweden |
Investor details for Nordic Vaccine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Nordic Vaccine
3 dated milestones of Nordic Vaccine across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Nordic Vaccine is founded.
- Exit Acquired by Isconova.
- Funding First funding round.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nordic Vaccine
Nordic Vaccine was founded in 2001 and raised its 1st funding round 10 years after it was founded.
Nordic Vaccine is headquartered in Copenhagen, Denmark.
Founded in 2001 in Copenhagen, Denmark, Nordic Vaccine operated in the biotechnology sector with a focus on research and development of adjuvants and drug delivery systems for vaccines. The companys portfolio featured the Posintro technology, a preclinical platform enabling needle-free vaccine delivery through dermal patches. Operations emphasized preclinical advancements until acquisition by Isconova in May 2011 for 663k.
Nordic Vaccine operates through Nordic Vaccine A/S.
Yes. Nordic Vaccine was acquired by Isconova in May 2011.